For the quarter ending 2025-09-30, ORGO has $509,827K in assets. $123,848K in debts. $63,745K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 63,745 | 73,076 | ||
| Restricted cash | 627 | 659 | ||
| Accounts receivable, net | 168,783 | 120,382 | ||
| Inventories, net | 39,583 | 33,042 | ||
| Asset held for sale (note 6) | 4,365 | 5,287 | ||
| Prepaid expenses and other current assets | 22,646 | 27,777 | ||
| Total current assets | 299,749 | 260,223 | ||
| Property and equipment, gross | 134,619 | - | ||
| Accumulated depreciation and amortization | 84,103 | - | ||
| Construction in progress | 27,542 | - | ||
| Property and equipment, net | 78,058 | 75,607 | ||
| Intangible assets, net | 9,943 | 10,785 | ||
| Goodwill | 28,772 | 28,772 | ||
| Operating lease right-of-use assets, net | 33,304 | 35,257 | ||
| Deferred tax asset, net | 45,591 | 41,754 | ||
| Other assets | 14,410 | 8,730 | ||
| Total assets | 509,827 | 461,128 | ||
| Current portion of finance lease obligations | 1,207 | 1,217 | ||
| Current portion of operating lease obligations - related party | 3,798 | 3,755 | ||
| Current portion of operating lease obligations | 4,785 | 4,796 | ||
| Accounts payable | 40,219 | 29,723 | ||
| Accrued expenses and other current liabilities | 40,310 | 26,348 | ||
| Total current liabilities | 90,319 | 65,839 | ||
| Finance lease obligations, net of current portion | 2,094 | 98 | ||
| Operating lease obligations, net of current portion - related party | 5,419 | 6,385 | ||
| Operating lease obligations, net of current portion | 23,507 | 24,565 | ||
| Other liabilities | 2,509 | 3,022 | ||
| Total liabilities | 123,848 | 99,909 | ||
| Series a redeemable convertible preferred stock, 0.0001 par value 130,000 shares authorized, issued and outstanding liquidation preference of 139,429 and 131,387 at september 30, 2025 and december 31, 2024, respectively | 130,851 | 127,977 | ||
| Common stock, 0.0001 par value 400,000,000 shares authorized 127,639,990 and 126,458,784 shares issued 126,911,442 and 125,730,236 shares outstanding at september 30, 2025 and december 31, 2024, respectively | 13 | 13 | ||
| Additional paid-in capital | 301,893 | 301,574 | ||
| Accumulated deficit | -46,778 | -68,345 | ||
| Total stockholders' equity | 255,128 | 233,242 | ||
| Total liabilities, redeemable convertible preferred stock, and stockholders' equity | 509,827 | 461,128 | ||
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)